• MDockPeP2_VS: Screening Peptides Against TEM-1

  2026-09-12

  The PNAS Nexus study introduces MDockPeP2_VS, a structure-based workflow that combines molecular docking with conservation between protein folding and protein–peptide binding to make large-scale peptide screening more practical. Applied to Escherichia coli TEM-1 β-lactamase, the approach identified TF7 as a micromolar inhibitor, providing a computational starting point for β-lactam antibiotic resistance research and follow-up biochemical validation.

• QPRT, P2Y11 Signaling, and Breast Cancer Invasion

  2026-09-12

  A Frontiers in Endocrinology study links elevated QPRT, a rate-limiting enzyme in de novo NAD+ synthesis, to breast cancer migration and invasion through a purinergic signaling–myosin light chain axis. Its paired genetic and pharmacological experiments provide a useful framework for testing how metabolic remodeling influences cytoskeletal behavior, while also highlighting limits in assigning direct P2Y11 receptor causality.

• Carrier-Platin and ROS-Driven Cancer Cell Death

  2026-09-11

  Liu and colleagues developed carrier-platin, a poly(amino acid)-based formulation containing ultrasmall platinum nanoparticles that rapidly amplifies intracellular reactive oxygen species. The study links this ROS burst to cancer-cell death within 30 minutes, including in multidrug-resistant models, through a mechanism distinct from conventional platinum-induced DNA damage, apoptosis, and ferroptosis.

• NADH Workflows for Redox and Mitochondrial Research

  2026-09-11

  Build more interpretable redox experiments with NADH, from cell-based metabolic perturbation to direct NADH/NAD⁺ measurement. This workflow connects mitochondrial electron transport chain research with Leigh syndrome models, diabetic nephropathy research, and emerging photocatalytic cancer therapy while emphasizing sample handling and assay controls.

• Doxycycline Workflows for Cancer Research

  2026-09-10

  Doxycycline supports more than antimicrobial experiments: it can help separate metalloproteinase-driven biology from direct cytotoxicity, while serving as a practical comparator in targeted cancer-delivery studies. This guide translates its formulation constraints into reproducible cell, enzyme, microbial, and nanocarrier workflows.

• Purmorphamine Workflows for Smoothened Signaling

  2026-09-10

  Build reproducible Hedgehog pathway assays with Purmorphamine, from osteogenic differentiation in mesenchymal cells to sensory signaling studies in honeybees. This workflow-led guide combines dose planning, orthogonal readouts, cross-species interpretation, and practical troubleshooting.

• Carbapenemase Gene Transmission in CREC

  2026-09-09

  A 2025 BMC Microbiology study analyzed carbapenem-resistant Enterobacter cloacae from eight teaching hospitals in Guangdong and combined gene localization, antimicrobial susceptibility testing, conjugation assays, mobile-element analysis, and ERIC-PCR typing. Its findings show that blaNDM-1 was frequently plasmid-associated and readily transferable, while clonal and mobile-element evidence together revealed overlapping horizontal and vertical dissemination pathways.

• Minocycline HCl: Mechanism and Research Use

  2026-09-09

  Minocycline HCl is a semisynthetic tetracycline antibiotic with established 30S-ribosome activity and widely studied anti-inflammatory effects. This article separates directly supported minocycline evidence from a 2025 extracellular-vesicle manufacturing benchmark so researchers can design clearer antimicrobial, inflammation, and neuroprotection studies.

• Insulin–AMPK Control of PINK1 mRNA in Neurons

  2026-09-08

  This preprint identifies an insulin–AMPK metabolic switch that controls whether Pink1 mRNA remains tethered to mitochondria in neurons, thereby regulating PINK1 ubiquitin-kinase activity and mitophagy. Its findings connect impaired insulin signaling, including an ApoE4-associated insulin-resistance model, with defective mitochondrial quality control and provide a framework for designing insulin perturbation experiments in neuronal cultures.

• PPT (Propyl Pyrazole Triol) for ERα Research

  2026-09-07

  PPT (Propyl Pyrazole Triol) is a potent, subtype-selective ERα agonist for controlled studies of estrogen receptor signaling. Product information reports approximately 410-fold ERα-over-ERβ selectivity, while the female LUAD study provides biomarker rationale but does not directly validate PPT in lung adenocarcinoma.

• Tetracycline Hydrochloride: Assay Reliability

  2026-09-07

  A scenario-based guide to using Tetracycline Hydrochloride in antimicrobial, co-culture, and assay-control workflows. It explains how SKU A2517 supports practical stock preparation, mechanism-aware interpretation, and evidence-based supplier selection without confusing bacterial inhibition with mammalian cytotoxicity.

• Vincristine Sulfate: Workflow & Optimization

  2026-09-05

  Build more reproducible cancer research assays with vincristine sulfate by linking microtubule disruption to dose-response, imaging, and recovery measurements. This workflow separates product-specific evidence from practical optimization, helping researchers compare cell-based and xenograft models without overinterpreting a single viability endpoint.

• EPSC-Derived MSC EVs: Scalable Biomanufacturing

  2026-09-04

  Gong et al. establish a bioreactor-based platform that converts extended pluripotent stem cells into renewable induced mesenchymal stromal cells and therapeutically active extracellular vesicles. The work links standardized cell expansion, continuous EV harvesting, and pulmonary fibrosis validation, providing a practical framework for improving EV manufacturing consistency and scale.

• Tigecycline Workflows for CREC Resistance Research

  2026-09-04

  Build reproducible Tigecycline susceptibility workflows around plasmid localization, carbapenemase profiling, and clonal transmission analysis. This glycylcycline antibiotic provides a complementary phenotype readout for multidrug-resistant Enterobacter cloacae research without treating genotype alone as a predictor of response.

• Tetracycline: Workflow, Selection, and Assay Design

  2026-09-04

  Tetracycline combines broad-spectrum antimicrobial activity with practical value as an antibiotic selection marker and ribosomal function probe. This guide shows how to build reproducible selection and protein-synthesis assays, while responsibly connecting upstream microbiological workflows to the LKB1–telomerase findings reported in lung adenocarcinoma research.

8447 records 1/564 page Next 12345 下5页 Last page